Long-term effects of a standard treatment of a depomedrol / lidocaine injection in carpal tunnel syndrome; a pilot study of the clinical and neurophysiological changes in the median nerve.

Many patients with a CTS will be treated with a corticosteroïdinjectie at the
carpal tunnel. After 6 weeks, the patient is monitored and reviewed for
clinical improvement. It is not routinely performed to do a clinical
neurophysiological research after the injection.
But give the complaints of the patient the improvement in the function of the
nerve and the nerve itself?
And this treatment is not only a delay of surgery, and can we save time and
healthcare costs by sending someone directly for surgery?

The purpose of this study is to see if we can predict which patients with CTS
are eligible for an injection, and which should be directly referred to a
surgeon. This to shorten the period of the patient's symptoms and to save
healthcare costs.

Prospectively studied with twenty patients with CTS symptoms at the neurology
of Haga Hospital. All patients, in the period of 02-01-2014, with a the carpal
tunnel and have had an injection will undergo a follow-up study. This will
consist of (if not routine), an additional EMG (conduction)test, a nerve
ultrasound and a questionnaire at 6 weeks and 6 months.

-